Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In Vitro, Oral Acute, and Repeated 28-Day Oral Dose Toxicity of a Mixed-Valence Polyoxovanadate Cluster.
Barbosa MM, Lima LMA, Alves WADS, Lima EKB, Silva LAD, Silva TDD, Postal K, Ramadan M, Kostenkova K, Gomes DA, Nunes GG, Pereira MC, Silva WED, Belian MF, Crans DC, Lira EC. Barbosa MM, et al. Among authors: lima lma. Pharmaceuticals (Basel). 2023 Aug 30;16(9):1232. doi: 10.3390/ph16091232. Pharmaceuticals (Basel). 2023. PMID: 37765040 Free PMC article.
Safety assessment of Bauhinia cheilantha Bong. Steud leaves extract: acute, sub-acute toxicity, antioxidant, and antihemolytic evaluations.
de Brito AL, Quixabeira CMT, de Lima LMA, Paz ST, Gomes ANP, de Souza Araújo TA, de Albuquerque UP, Gomes DA, Silva TMS, Lira EC. de Brito AL, et al. Among authors: de lima lma. Toxicol Res (Camb). 2021 May 29;10(3):613-626. doi: 10.1093/toxres/tfab044. eCollection 2021 May. Toxicol Res (Camb). 2021. PMID: 34141175 Free PMC article.
Anesthesia in patient with lead poisoning: case report.
de Lima LM, Resende FC, dos Santos AC, Terra PP, Pantoja AV, de Resende MA. de Lima LM, et al. Rev Bras Anestesiol. 2012 Nov-Dec;62(6):863-8. doi: 10.1016/S0034-7094(12)70186-1. Rev Bras Anestesiol. 2012. PMID: 23176994 Free article.
Short-term treatment with metformin improves the cardiovascular risk profile in first-degree relatives of subjects with type 2 diabetes mellitus who have a metabolic syndrome and normal glucose tolerance without changes in C-reactive protein or fibrinogen.
Lima LM, Wiernsperger N, Kraemer-Aguiar LG, Bouskela E. Lima LM, et al. Clinics (Sao Paulo). 2009 May;64(5):415-20. doi: 10.1590/s1807-59322009000500008. Clinics (Sao Paulo). 2009. PMID: 19488607 Free PMC article. Clinical Trial.